این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
چهارشنبه 28 آبان 1404
مجله علوم اعصاب شفای خاتم
، جلد ۵، شماره ۲، صفحات ۱۸۳-۱۸۳
عنوان فارسی
P ۱۵۲: Mesenchymal Stem Cells as a Therapeutic Target in Multiple Sclerosis
چکیده فارسی مقاله
لطفاً به چکیده انگلیسی مراجعه شود.
کلیدواژههای فارسی مقاله
عنوان انگلیسی
P 152: Mesenchymal Stem Cells as a Therapeutic Target in Multiple Sclerosis
چکیده انگلیسی مقاله
Neuroinflammation has a significant role in induce of Multiple sclerosis (MS) many approaches have been used to treat MS, but none of these methods have not been able to fully improve. One of the methods can suppress inflammation and regenerate the nervous system is the use of cell therapy. Using cell therapy in pre-clinic phase can be realized, it's mechanism and potency to suppress neuroinflammation. The best way that plenty of researchers use it to simulate the MS condition is experimental autoimmune encephalomyelitis (EAE) which is method can be induced neuroinflammation in laboratory animals. In this context, a lot of researches have been done on EAE model. Many of these studies have been done on mesenchymal stem cells (MSC). MSC is a heterogeneous subset of, mesoderm stromal progenitor cells that are almost derived from connective tissue. MSCs can be obtained from adipose tissue, bone marrow, and umbilical cord that regulatory and inhibitory effect on the immune system. Transplantation of adipose-derived stem cell (ASCs) has demonstrated striking therapeutic effects and unique immunomodulatory capacities when delivered at the peak or later in the course of the disease in EAE rats. Recent studies have shown that umbilical cord-derived mesenchymal stem cells (UC-MSCs) exert a regulatory effect on the functions of immune cells. UC-MSCs could improve the impaired function of T-regulator cells (Treg) from MS patients and also enhanced the capacity of Tregs to release IL-10. There is still controversy about the use of UC-MSCs and ASCs, and more research is needed to determine the advantages and the disadvantages of them also in vitro method such as EAE cannot simulate all condition of disease therefor more research in clinical phase should be done.
کلیدواژههای انگلیسی مقاله
Multiple sclerosis, Cell therapy, Neuroinflammation
نویسندگان مقاله
علی شریعت رضوی | ali shariat razavi
medicine faculty, islamic azad university, mashhad branch, mashhad, iran
سازمان اصلی تایید شده
: دانشگاه آزاد اسلامی علوم و تحقیقات (Islamic azad university science and research branch)
محمدرضا خجسته | mohammad reza khojasteh
medicine faculty, islamic azad university, mashhad branch, mashhad, iran
سازمان اصلی تایید شده
: دانشگاه آزاد اسلامی علوم و تحقیقات (Islamic azad university science and research branch)
آیدا جواد زاده | aida java zadeh
medicine faculty, islamic azad university, mashhad branch, mashhad, iran
سازمان اصلی تایید شده
: دانشگاه آزاد اسلامی علوم و تحقیقات (Islamic azad university science and research branch)
سجاد سحاب نگاه | sajad sahab negah
a. department of neuroscience, mashhad university of medical sciences, mashhad, iran b. shefa neuroscience research center, khatam alanbia hospital, tehran, iran
shefa neuroscience research center, khatam alanbia hospital, tehran, iran
سازمان اصلی تایید شده
: مرکز تحقیقات علوم اعصاب شفا (Shefa neuroscience research center)
نشانی اینترنتی
http://shefayekhatam.ir/browse.php?a_code=A-10-24-1003&slc_lang=en&sid=fa
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/337/article-337-393456.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
fa
موضوعات مقاله منتشر شده
تحقیقات پایه در علوم اعصاب
نوع مقاله منتشر شده
مروری
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات